-
1
-
-
0002339554
-
Epidemiology of hepatocellular carcinoma
-
Springer, Tokyo, K. Okuda, K. Ishak (Eds.)
-
Munoz N., Bosch F.X. Epidemiology of hepatocellular carcinoma. Neoplasms of the Liver 1989, 3-19. Springer, Tokyo. K. Okuda, K. Ishak (Eds.).
-
(1989)
Neoplasms of the Liver
, pp. 3-19
-
-
Munoz, N.1
Bosch, F.X.2
-
2
-
-
79951685785
-
Cancer Incidence in Five Continents 5 (IARC Publications. Number 88)
-
International Agency for Research on Cancer, Lyon
-
Muir C., Waterhouse K., Mack T., et al. Cancer Incidence in Five Continents 5 (IARC Publications. Number 88). Manual of Clinical Oncology 1987, International Agency for Research on Cancer, Lyon.
-
(1987)
Manual of Clinical Oncology
-
-
Muir, C.1
Waterhouse, K.2
Mack, T.3
-
3
-
-
0002247314
-
Hepatocellular carcinoma in the world: epidemiologic questions
-
Houston, Gulf, E. Tabor, P.R.H. Am DiBisceglie (Eds.)
-
Bosch F.X., Munoz N. Hepatocellular carcinoma in the world: epidemiologic questions. Etiology, Pathology and Treatment of Hepatocellular Carcinoma in America: Advances in Applied Technology Series 1991, 35-54. Houston, Gulf. E. Tabor, P.R.H. Am DiBisceglie (Eds.).
-
(1991)
Etiology, Pathology and Treatment of Hepatocellular Carcinoma in America: Advances in Applied Technology Series
, pp. 35-54
-
-
Bosch, F.X.1
Munoz, N.2
-
4
-
-
0004923263
-
Epidemiology of primary liver cancer
-
Springer, Tokyo, T. Tobe (Ed.)
-
Okuda K. Epidemiology of primary liver cancer. Primary Liver Cancer in Japan 1992, 3. Springer, Tokyo. T. Tobe (Ed.).
-
(1992)
Primary Liver Cancer in Japan
, pp. 3
-
-
Okuda, K.1
-
5
-
-
0035467993
-
Global cancer statistics in the year 2000
-
Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2001, 2:533-543.
-
(2001)
Lancet Oncol
, vol.2
, pp. 533-543
-
-
Parkin, D.M.1
-
6
-
-
7044264264
-
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study
-
Davila J.A., Morgan R.O., Shaib Y., et al. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004, 127:1372-1380.
-
(2004)
Gastroenterology
, vol.127
, pp. 1372-1380
-
-
Davila, J.A.1
Morgan, R.O.2
Shaib, Y.3
-
7
-
-
0033852937
-
Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases
-
Bralet M.P., Regimbeau J.M., Pineau P., et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. J Hepatol 2000, 32:200-204.
-
(2000)
J Hepatol
, vol.32
, pp. 200-204
-
-
Bralet, M.P.1
Regimbeau, J.M.2
Pineau, P.3
-
9
-
-
0031782818
-
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators
-
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatol 1998, 28:751-755.
-
(1998)
Hepatol
, vol.28
, pp. 751-755
-
-
-
10
-
-
0021965806
-
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients
-
Okuda K., Ohtsuki T., Obata H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985, 56:918-928.
-
(1985)
Cancer
, vol.56
, pp. 918-928
-
-
Okuda, K.1
Ohtsuki, T.2
Obata, H.3
-
11
-
-
0034107047
-
Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) investigators
-
Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) investigators. J Hepatol 2000, 31:840-845.
-
(2000)
J Hepatol
, vol.31
, pp. 840-845
-
-
-
12
-
-
0034544613
-
How should patients with hepatocellular carcinoma be staged?. Validation of a new prognostic system
-
Farinati F., Rinaldi M., Gianni S., et al. How should patients with hepatocellular carcinoma be staged?. Validation of a new prognostic system. Cancer 2000, 89:2266-2273.
-
(2000)
Cancer
, vol.89
, pp. 2266-2273
-
-
Farinati, F.1
Rinaldi, M.2
Gianni, S.3
-
13
-
-
0033066135
-
A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude de Traitement du Carcinome Hepatocellulaire
-
Chevret S., Trinchet J.C., Mathieu D., et al. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude de Traitement du Carcinome Hepatocellulaire. J Hepatol 1999, 31:133-141.
-
(1999)
J Hepatol
, vol.31
, pp. 133-141
-
-
Chevret, S.1
Trinchet, J.C.2
Mathieu, D.3
-
14
-
-
0032879468
-
Prognosis of hepatocellular carcinoma: the BCLC staging classification
-
Llovet J.M., Bru C., Bruix K. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999, 19:329-338.
-
(1999)
Semin Liver Dis
, vol.19
, pp. 329-338
-
-
Llovet, J.M.1
Bru, C.2
Bruix, K.3
-
15
-
-
79951688049
-
Liver cancer
-
Wiley-Liss, New York, R.E. Pollock (Ed.)
-
Tang Z.Y. Liver cancer. Manual of Clinical Oncology 1999, 407-424. Wiley-Liss, New York. R.E. Pollock (Ed.).
-
(1999)
Manual of Clinical Oncology
, pp. 407-424
-
-
Tang, Z.Y.1
-
16
-
-
0016833599
-
A staging system for hepatocellular carcinoma: prognostic factors in Ugandan patients
-
Primack A., Vogel C.L., Kyalwazi S.K., et al. A staging system for hepatocellular carcinoma: prognostic factors in Ugandan patients. Cancer 1975, 35:1357-1364.
-
(1975)
Cancer
, vol.35
, pp. 1357-1364
-
-
Primack, A.1
Vogel, C.L.2
Kyalwazi, S.K.3
-
17
-
-
0019475636
-
Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong
-
Lai C.L., Lam K.C., Wong K.P., et al. Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong. Cancer 1981, 47:2746-2755.
-
(1981)
Cancer
, vol.47
, pp. 2746-2755
-
-
Lai, C.L.1
Lam, K.C.2
Wong, K.P.3
-
18
-
-
0346896573
-
AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement
-
Henderson J., Sherman M., Tavill A., et al. AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB 2003, 5:243-250.
-
(2003)
HPB
, vol.5
, pp. 243-250
-
-
Henderson, J.1
Sherman, M.2
Tavill, A.3
-
19
-
-
79951717986
-
Preoperative sequential TACE and PVE to increase respectability in the cirrhotic patient with HCC
-
Choti M.A., Geschwind K.F. Preoperative sequential TACE and PVE to increase respectability in the cirrhotic patient with HCC. Gastrointest Cancer Res 2008, 2:47-48.
-
(2008)
Gastrointest Cancer Res
, vol.2
, pp. 47-48
-
-
Choti, M.A.1
Geschwind, K.F.2
-
20
-
-
0345299824
-
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
-
Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334:693-699.
-
(1996)
N Engl J Med
, vol.334
, pp. 693-699
-
-
Mazzaferro, V.1
Regalia, E.2
Doci, R.3
-
21
-
-
33748759267
-
Radioembolization with yttrium-90 microspheres: a state of the art brachytherapy treatment for primary and secondary liver malignancies. II. Special topics
-
Salem R., Thurston K.G. Radioembolization with yttrium-90 microspheres: a state of the art brachytherapy treatment for primary and secondary liver malignancies. II. Special topics. J Vasc Interv Radiol 2006, 17:1425-1439.
-
(2006)
J Vasc Interv Radiol
, vol.17
, pp. 1425-1439
-
-
Salem, R.1
Thurston, K.G.2
-
23
-
-
0025123654
-
Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium
-
Konno T. Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium. Cancer 1990, 66:1897-1903.
-
(1990)
Cancer
, vol.66
, pp. 1897-1903
-
-
Konno, T.1
-
24
-
-
0024521344
-
Transcatheter oily chemoembolization of hepatocellular carcinoma
-
Nakamura H., Hashimoto T., Oi H., et al. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1989, 170:783-786.
-
(1989)
Radiology
, vol.170
, pp. 783-786
-
-
Nakamura, H.1
Hashimoto, T.2
Oi, H.3
-
25
-
-
0344051547
-
Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. Meta-Analysis Group in cancer
-
Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. Meta-Analysis Group in cancer. J Natl Cancer Inst 1996, 88:252-282.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 252-282
-
-
-
26
-
-
0036085956
-
Transarterial chemoembolization for uresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials
-
Camma C., Schepis F., Orlando A., et al. Transarterial chemoembolization for uresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002, 224:47-54.
-
(2002)
Radiology
, vol.224
, pp. 47-54
-
-
Camma, C.1
Schepis, F.2
Orlando, A.3
-
27
-
-
33845402644
-
Transarterial therapy for hepatocellular carcinoma: which technique is more effective?. A systematic review of cohort and randomized studies
-
Marelli L., Stigliano R., Triantos C., et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective?. A systematic review of cohort and randomized studies. Cardiovasc Interv Radiol 2007, 30:6-25.
-
(2007)
Cardiovasc Interv Radiol
, vol.30
, pp. 6-25
-
-
Marelli, L.1
Stigliano, R.2
Triantos, C.3
-
28
-
-
0027687532
-
In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver tumors
-
Kruskal J.B., Hlatky L., Hahnfeldt P., et al. In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver tumors. J Vasc Interv Radiol 1993, 4:741-747.
-
(1993)
J Vasc Interv Radiol
, vol.4
, pp. 741-747
-
-
Kruskal, J.B.1
Hlatky, L.2
Hahnfeldt, P.3
-
30
-
-
33745039214
-
Technology insight: image guided therapies for hepatocellular carcinoma -intra-arterial and ablative techniques
-
Hong K., Georgiades C.S., Geschwind J.F. Technology insight: image guided therapies for hepatocellular carcinoma -intra-arterial and ablative techniques. Nat Clin Pract Oncol 2006, 3:315-354.
-
(2006)
Nat Clin Pract Oncol
, vol.3
, pp. 315-354
-
-
Hong, K.1
Georgiades, C.S.2
Geschwind, J.F.3
-
31
-
-
0031874090
-
Transcatheter arterial chemoembolization of hepatocellular carcinoma
-
Chung J.W. Transcatheter arterial chemoembolization of hepatocellular carcinoma. Hepato Gastroenterol 1998, 45(suppl 3):1236-1241.
-
(1998)
Hepato Gastroenterol
, vol.45
, Issue.SUPPL. 3
, pp. 1236-1241
-
-
Chung, J.W.1
-
32
-
-
33744717858
-
Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents
-
Brown D.B., Pilgram T.K., Darcy M.D., et al. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol 2005, 16:1661-1666.
-
(2005)
J Vasc Interv Radiol
, vol.16
, pp. 1661-1666
-
-
Brown, D.B.1
Pilgram, T.K.2
Darcy, M.D.3
-
33
-
-
33846847728
-
Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics
-
Varela M., Real M.I., Burrel M., et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 2007, 46:474-481.
-
(2007)
J Hepatol
, vol.46
, pp. 474-481
-
-
Varela, M.1
Real, M.I.2
Burrel, M.3
-
34
-
-
41049116317
-
Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients
-
Malagari K., Chatzmichael K., Alexopoulou E., et al. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Interv Radiol 2008, 31:269-280.
-
(2008)
Cardiovasc Interv Radiol
, vol.31
, pp. 269-280
-
-
Malagari, K.1
Chatzmichael, K.2
Alexopoulou, E.3
-
35
-
-
79951717795
-
Transarterial chemoembolization (TACE) with doxorubicin-eluting beads for the treatment of hepatocellular carcinoma
-
Vit A., DePauli F., Sponza M., et al. Transarterial chemoembolization (TACE) with doxorubicin-eluting beads for the treatment of hepatocellular carcinoma. J Clin Oncol 2008, 26:237-242.
-
(2008)
J Clin Oncol
, vol.26
, pp. 237-242
-
-
Vit, A.1
DePauli, F.2
Sponza, M.3
-
36
-
-
75149112376
-
Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States
-
Reyes D.K., Vossen J.A., Kamel I.R., et al. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J 2009, 15:526-532.
-
(2009)
Cancer J
, vol.15
, pp. 526-532
-
-
Reyes, D.K.1
Vossen, J.A.2
Kamel, I.R.3
-
37
-
-
55849105861
-
Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study
-
Grosso M., Vignali C., Quaretti P., et al. Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study. Cardiovasc Interv Radiol 2008, 31:1141-1149.
-
(2008)
Cardiovasc Interv Radiol
, vol.31
, pp. 1141-1149
-
-
Grosso, M.1
Vignali, C.2
Quaretti, P.3
-
38
-
-
77953138048
-
Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma
-
Malagari K., Pomoni M., Kelekis A., et al. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Interv Radiol 2010, 33:541-551.
-
(2010)
Cardiovasc Interv Radiol
, vol.33
, pp. 541-551
-
-
Malagari, K.1
Pomoni, M.2
Kelekis, A.3
-
39
-
-
77949264899
-
Prospective randomized study of doxorubicin eluting bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study
-
Lammer J., Malagari K., Vogl T., et al. Prospective randomized study of doxorubicin eluting bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Interv Radiol 2010, 33:41-52.
-
(2010)
Cardiovasc Interv Radiol
, vol.33
, pp. 41-52
-
-
Lammer, J.1
Malagari, K.2
Vogl, T.3
-
40
-
-
7044231876
-
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma
-
Geschwind J.F., Salem R., Carr B.I., et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 2004, 127:S194-S205.
-
(2004)
Gastroenterology
, vol.127
-
-
Geschwind, J.F.1
Salem, R.2
Carr, B.I.3
-
41
-
-
0032005472
-
Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of yttrium-90 microspheres
-
Lau W.Y., Ho S., Leung T.W., et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of yttrium-90 microspheres. Int J Radiat Oncol Biol Phys 1998, 40:583-592.
-
(1998)
Int J Radiat Oncol Biol Phys
, vol.40
, pp. 583-592
-
-
Lau, W.Y.1
Ho, S.2
Leung, T.W.3
-
42
-
-
0033123518
-
Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer
-
Cao X., He N., Sun J., et al. Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer. Chin Med J [Engl] 1999, 112:430-432.
-
(1999)
Chin Med J [Engl]
, vol.112
, pp. 430-432
-
-
Cao, X.1
He, N.2
Sun, J.3
-
43
-
-
0033778282
-
Treatment of nonresectable hepatocellular carcinoma with intrahepatic Y-90 microsphere
-
Dancey J.E., Shepherd F.A., Paul K., et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic Y-90 microsphere. J Nucl Med 2000, 41:1673-1681.
-
(2000)
J Nucl Med
, vol.41
, pp. 1673-1681
-
-
Dancey, J.E.1
Shepherd, F.A.2
Paul, K.3
-
44
-
-
33748798922
-
Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation
-
Kulik L.M., Atassi B., van Holsbeeck L., et al. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 2006, 94:572-586.
-
(2006)
J Surg Oncol
, vol.94
, pp. 572-586
-
-
Kulik, L.M.1
Atassi, B.2
van Holsbeeck, L.3
-
45
-
-
33748927955
-
Radioembolization using Y-90 resin microspheres for patients with advanced hepatocellular carcinoma
-
Sangro B., Bilbao J.I., Boan J., et al. Radioembolization using Y-90 resin microspheres for patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2006, 66:792-800.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.66
, pp. 792-800
-
-
Sangro, B.1
Bilbao, J.I.2
Boan, J.3
-
46
-
-
62649136459
-
Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured metaanalysis
-
Vente M.A., Wondergem M., van der Tweel I., et al. Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured metaanalysis. Eur Radiol 2009, 19:951-959.
-
(2009)
Eur Radiol
, vol.19
, pp. 951-959
-
-
Vente, M.A.1
Wondergem, M.2
van der Tweel, I.3
-
47
-
-
72249087123
-
Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long term outcomes
-
Salem R., Lewandowski R.L., Mulcahy M.F., et al. Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long term outcomes. Gastroenterology 2010, 138:52-64.
-
(2010)
Gastroenterology
, vol.138
, pp. 52-64
-
-
Salem, R.1
Lewandowski, R.L.2
Mulcahy, M.F.3
-
48
-
-
47949116252
-
Sorafenib in advanced hepatocellular carcinoma
-
Llovet J.M., Ricci S., Mazzaferro V., et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008, 359:378-390.
-
(2008)
N Engl J Med
, vol.359
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
-
49
-
-
0037086539
-
A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma
-
Chan A.O., Yuen M.F., Hui C.K., et al. A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 2002, 94:1747-1752.
-
(2002)
Cancer
, vol.94
, pp. 1747-1752
-
-
Chan, A.O.1
Yuen, M.F.2
Hui, C.K.3
-
50
-
-
0035107928
-
Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome
-
Song S.Y., Chung J.W., Han J.K., et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol 2001, 12:313-320.
-
(2001)
J Vasc Interv Radiol
, vol.12
, pp. 313-320
-
-
Song, S.Y.1
Chung, J.W.2
Han, J.K.3
-
51
-
-
0035041214
-
Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma
-
Kim H.K., Chung Y.H., Song B.C., et al. Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 2001, 32:423-427.
-
(2001)
J Clin Gastroenterol
, vol.32
, pp. 423-427
-
-
Kim, H.K.1
Chung, Y.H.2
Song, B.C.3
-
52
-
-
39749190526
-
Chemoembolization of hepatocellular carcinoma: patient status at presentation and outcome over 15 years at a single center
-
Brown D.B., Chapman W.C., Cook R.D., et al. Chemoembolization of hepatocellular carcinoma: patient status at presentation and outcome over 15 years at a single center. AJR Am J Roentgenol 2008, 190:608-615.
-
(2008)
AJR Am J Roentgenol
, vol.190
, pp. 608-615
-
-
Brown, D.B.1
Chapman, W.C.2
Cook, R.D.3
-
53
-
-
28844480321
-
Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of Hepatocellular Carcinoma
-
Bruix J., Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of Hepatocellular Carcinoma. J Hepatol 2005, 42:1208-1236.
-
(2005)
J Hepatol
, vol.42
, pp. 1208-1236
-
-
Bruix, J.1
Sherman, M.2
|